Vile R, Pulido J, Chen A, Kendall B, Tonne J, Metko M, et al. Cancer Immunotherapy Using AIRE Conditioning of the Tumor Epitopeome. Res Sq. 2024;: pubmed publisher

McMurphy T, Park A, Heizer P, Bottenfield C, Kurasawa J, Ikeda Y, et al. AAV-mediated co-expression of an immunogenic transgene plus PD-L1 enables sustained expression through immunological evasion. Sci Rep. 2024;14:28853 pubmed publisher

Wan L, Xie B, Shuda M, Delgoffe G, Chang Y, Moore P. Engineered protein destabilization reverses intrinsic immune evasion for candidate vaccine pan-strain KSHV and SARS-CoV-2 antigens. bioRxiv. 2024;: pubmed publisher

Kim K, Moon S, Kim S, Ouh I, Lee Y, Lim H. Immunogenicity Analysis of Chikungunya Virus DNA Vaccine Based on Mutated Putative N-Linked Glycosylation Sites of the Envelope Protein. Vaccines (Basel). 2024;12: pubmed publisher

Najar T, Hao Y, Hao Y, Romero Meza G, Dolynuk A, Littman D. Microbiota-induced plastic T cells enhance immune control of antigen-sharing tumors. bioRxiv. 2024;: pubmed publisher

Alsaiari S, Nadeef S, Daristotle J, Rothwell W, Du B, Garcia J, et al. Zeolitic imidazolate frameworks activate endosomal Toll-like receptors and potentiate immunogenicity of SARS-CoV-2 spike protein trimer. Sci Adv. 2024;10:eadj6380 pubmed publisher

Li J, Canham S, Wu H, Henault M, Chen L, Liu G, et al. Activation of human STING by a molecular glue-like compound. Nat Chem Biol. 2024;20:365-372 pubmed publisher

Wang M, Rousseau B, Qiu K, Huang G, Zhang Y, Su H, et al. Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses. Nat Biotechnol. 2024;42:1263-1274 pubmed publisher

Zhivaki D, Gosselin E, Sengupta D, Concepcion H, Arinze C, Chow J, et al. mRNAs encoding self-DNA reactive cGAS enhance the immunogenicity of lipid nanoparticle vaccines. MBio. 2023;14:e0250623 pubmed publisher

Ko M, Kim H, Park S, Park J, Kim S, Lee M. The role of zinc sulfate in enhancing cellular and humoral immune responses to foot-and-mouth disease vaccine. Virus Res. 2023;335:199189 pubmed publisher

Wang Z, Li Z, Shi W, Zhu D, Hu S, Dinh P, et al. A SARS-CoV-2 and influenza double hit vaccine based on RBD-conjugated inactivated influenza A virus. Sci Adv. 2023;9:eabo4100 pubmed publisher

Eddens T, Parks O, Lou D, Fan L, Sojati J, Ramsey M, et al. Monocyte production of C1q potentiates CD8 + T cell effector function following respiratory viral infection. bioRxiv. 2023;: pubmed publisher

Mu xf1 oz Al xed a M, Nace R, Balakrishnan B, Zhang L, Packiriswamy N, Singh G, et al. Surface-modified measles vaccines encoding oligomeric, fusion-stabilized SARS-CoV-2 spike glycoproteins bypass measles seropositivity, boosting neutralizing antibody responses to omicron and historical variants. bioRxiv. 2022;: pubmed publisher

Lim J, Kishnani P, Sun B. Suppression of pullulanase-induced cytotoxic T cell response with a dual promoter in GSD IIIa mice. JCI Insight. 2022;7: pubmed publisher

Shchelkunov S, Yakubitskiy S, Sergeev A, Starostina E, Titova K, Pyankov S, et al. Enhancing the Immunogenicity of Vaccinia Virus. Viruses. 2022;14: pubmed publisher

Hong Y, Robbins Y, Yang X, Mydlarz W, Sowers A, Mitchell J, et al. Cure of syngeneic carcinomas with targeted IL-12 through obligate reprogramming of lymphoid and myeloid immunity. JCI Insight. 2022;7: pubmed publisher

Klingler S, Hsu K, Hua G, Martin M, Adileh M, Baslan T, et al. Disruption of the crypt niche promotes outgrowth of mutated colorectal tumor stem cells. JCI Insight. 2022;7: pubmed publisher

Borgoyakova M, Karpenko L, Rudometov A, Volosnikova E, Merkuleva I, Starostina E, et al. Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice. Int J Mol Sci. 2022;23: pubmed publisher

Okada H, Takahashi K, Yaku H, Kobiyama K, Iwaisako K, Zhao X, et al. In situ vaccination using unique TLR9 ligand K3-SPG induces long-lasting systemic immune response and synergizes with systemic and local immunotherapy. Sci Rep. 2022;12:2132 pubmed publisher

Uraki R, Imai M, Ito M, Shime H, Odanaka M, Okuda M, et al. Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens. PLoS Pathog. 2021;17:e1010085 pubmed publisher

Jiang W, Shi L, Cai L, Wang X, Li J, Li H, et al. A two-adjuvant multiantigen candidate vaccine induces superior protective immune responses against SARS-CoV-2 challenge. Cell Rep. 2021;37:110112 pubmed publisher

Shchelkunov S, Sergeev A, Yakubitskiy S, Titova K, Pyankov S, Kolosova I, et al. Adaptive Immune Response to Vaccinia Virus LIVP Infection of BALB/c Mice and Protection against Lethal Reinfection with Cowpox Virus. Viruses. 2021;13: pubmed publisher

Hwang H, Cherukula K, Bang Y, Vijayan V, Moon M, Thiruppathi J, et al. Combination of Photodynamic Therapy and a Flagellin-Adjuvanted Cancer Vaccine Potentiated the Anti-PD-1-Mediated Melanoma Suppression. Cells. 2020;9: pubmed publisher

Dubé J, McIntosh F, Zarruk J, David S, Nigou J, Behr M. Synthetic mycobacterial molecular patterns partially complete Freund's adjuvant. Sci Rep. 2020;10:5874 pubmed publisher

Aligholipour Farzani T, Földes K, Ergunay K, Gurdal H, Baştuğ A, Ozkul A. Immunological Analysis of a CCHFV mRNA Vaccine Candidate in Mouse Models. Vaccines (Basel). 2019;7: pubmed publisher

Deng J, Wang X, Zhang B, Gao P, Lin Q, Kao R, et al. Broad and Effective Protection against Staphylococcus aureus Is Elicited by a Multivalent Vaccine Formulated with Novel Antigens. mSphere. 2019;4: pubmed publisher

Mohseni A, Taghinezhad S S, Keyvani H, Razavilar V. Extracellular overproduction of E7 oncoprotein of Iranian human papillomavirus type 16 by genetically engineered Lactococcus lactis. BMC Biotechnol. 2019;19:8 pubmed publisher

Gage E, Van Hoeven N, Dubois Cauwelaert N, Larsen S, Erasmus J, Orr M, et al. Memory CD4+ T cells enhance B-cell responses to drifting influenza immunization. Eur J Immunol. 2019;49:266-276 pubmed publisher

Taghinezhad S S, Mohseni A, Keyvani H, Razavilar V. Protection against human papillomavirus type 16-induced tumors in C57BL/6 mice by mucosal vaccination with Lactococcus lactis NZ9000 expressing E6 oncoprotein. Microb Pathog. 2019;126:149-156 pubmed publisher

Xu C, Zhang B, Lin Q, Deng J, Yu B, Arya S, et al. Live attenuated Salmonella typhimurium vaccines delivering SaEsxA and SaEsxB via type III secretion system confer protection against Staphylococcus aureus infection. BMC Infect Dis. 2018;18:195 pubmed publisher

Sun W, Shi J, Wu J, Zhang J, Chen H, Li Y, et al. A modified HLA-A*0201-restricted CTL epitope from human oncoprotein (hPEBP4) induces more efficient antitumor responses. Cell Mol Immunol. 2018;15:768-781 pubmed publisher

Lahey T, Laddy D, Hill K, Schaeffer J, Hogg A, Keeble J, et al. Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis. PLoS ONE. 2016;11:e0168521 pubmed publisher

Gil Farina I, Di Scala M, Salido E, Lopez Franco E, Rodríguez Garcia E, Blasi M, et al. Transient Expression of Transgenic IL-12 in Mouse Liver Triggers Unremitting Inflammation Mimicking Human Autoimmune Hepatitis. J Immunol. 2016;197:2145-56 pubmed publisher

King T, Kemmler C, Guo Z, Mann D, Lu Y, COESHOTT C, et al. A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance. PLoS ONE. 2014;9:e101904 pubmed publisher

Reynolds C, Chong D, Raynsford E, Quigley K, Kelly D, Llewellyn Hughes J, et al. Elongated TCR alpha chain CDR3 favors an altered CD4 cytokine profile. BMC Biol. 2014;12:32 pubmed publisher

Kumari S, Herzberg B, Pofahl R, Krieg T, Haase I. Epidermal RelA specifically restricts contact allergen-induced inflammation and apoptosis in skin. J Invest Dermatol. 2014;134:2541-2550 pubmed publisher

Kanagavelu S, Termini J, Gupta S, Raffa F, Fuller K, Rivas Y, et al. HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity. PLoS ONE. 2014;9:e90100 pubmed publisher

Lv L, Li X, Liu G, Li R, Liu Q, Shen H, et al. Production and immunogenicity of chimeric virus-like particles containing the spike glycoprotein of infectious bronchitis virus. J Vet Sci. 2014;15:209-16 pubmed

Gupta S, Termini J, Raffa F, Williams C, Kornbluth R, Stone G. Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag. J Virol. 2014;88:1492-501 pubmed publisher

Walsh M, Duncan B, Larabee S, Krauss A, Davis J, Cui Y, et al. Val-boroPro accelerates T cell priming via modulation of dendritic cell trafficking resulting in complete regression of established murine tumors. PLoS ONE. 2013;8:e58860 pubmed publisher

Savino M, Ulivieri C, Emmi G, Prisco D, De Falco G, Ortensi B, et al. The Shc family protein adaptor, Rai, acts as a negative regulator of Th17 and Th1 cell development. J Leukoc Biol. 2013;93:549-59 pubmed publisher

Wu C, Yeh Y, Chan J, Yang Y, Yang J, Liu M, et al. A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus. PLoS ONE. 2012;7:e42363 pubmed publisher

Mölder T, Adojaan M, Kaldma K, Ustav M, Sikut R. Elicitation of broad CTL response against HIV-1 by the DNA vaccine encoding artificial multi-component fusion protein MultiHIV--study in domestic pigs. Vaccine. 2009;28:293-8 pubmed publisher

Robinson M, Li B, Ge Y, Ko D, Yendluri S, Harding T, et al. Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors. J Virol. 2009;83:3450-62 pubmed publisher

Zhu Q, Thomson C, Rosenthal K, McDermott M, Collins S, Gauldie J. Immunization with adenovirus at the large intestinal mucosa as an effective vaccination strategy against sexually transmitted viral infection. Mucosal Immunol. 2008;1:78-88 pubmed publisher

Divangahi M, Mostowy S, Coulombe F, Kozak R, Guillot L, Veyrier F, et al. NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J Immunol. 2008;181:7157-65 pubmed

Lopez R, Demick K, Mansfield J, Paulnock D. Type I IFNs play a role in early resistance, but subsequent susceptibility, to the African trypanosomes. J Immunol. 2008;181:4908-17 pubmed

Yang J, Popoola J, Khandwala S, Vadivel N, Vanguri V, Yuan X, et al. Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy. Circulation. 2008;117:660-9 pubmed publisher

Koncz A, Pasztoi M, Mazan M, Fazakas F, Buzas E, Falus A, et al. Nitric oxide mediates T cell cytokine production and signal transduction in histidine decarboxylase knockout mice. J Immunol. 2007;179:6613-9 pubmed

Barcia C, Jimenez Dalmaroni M, Kroeger K, Puntel M, Rapaport A, Larocque D, et al. One-year expression from high-capacity adenoviral vectors in the brains of animals with pre-existing anti-adenoviral immunity: clinical implications. Mol Ther. 2007;15:2154-63 pubmed

Kurooka M, Kaneda Y. Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells. Cancer Res. 2007;67:227-36 pubmed

Young K, Ross T. Elicitation of immunity to HIV type 1 Gag is determined by Gag structure. AIDS Res Hum Retroviruses. 2006;22:99-108 pubmed

Wang D, Li Y, Yu D, Song S, Kandimalla E, Agrawal S. Immunopharmacological and antitumor effects of second-generation immunomodulatory oligonucleotides containing synthetic CpR motifs. Int J Oncol. 2004;24:901-8 pubmed